Current and historical daily PE Ratio for Asymchem Laboratories Tianjin Co Ltd (
) from 2016 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Asymchem Laboratories Tianjin stock (SZSE:002821) PE ratio as of Jun 09 2024 is 13.98.
More Details
Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) PE Ratio (TTM) Chart
Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Asymchem Laboratories Tianjin PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 14.0 | 2024-04-01 | 16.4 |
| 2024-06-07 | 14.0 | 2024-03-29 | 16.2 |
| 2024-06-06 | 14.1 | 2024-03-28 | 16.9 |
| 2024-06-05 | 14.3 | 2024-03-27 | 14.3 |
| 2024-06-04 | 14.5 | 2024-03-26 | 14.6 |
| 2024-06-03 | 14.2 | 2024-03-25 | 14.9 |
| 2024-05-31 | 14.5 | 2024-03-22 | 14.9 |
| 2024-05-30 | 14.4 | 2024-03-21 | 15.4 |
| 2024-05-29 | 14.5 | 2024-03-20 | 15.6 |
| 2024-05-28 | 14.4 | 2024-03-19 | 15.6 |
| 2024-05-27 | 14.4 | 2024-03-18 | 16.1 |
| 2024-05-24 | 14.6 | 2024-03-15 | 16.0 |
| 2024-05-23 | 14.9 | 2024-03-14 | 16.2 |
| 2024-05-22 | 15.2 | 2024-03-13 | 16.4 |
| 2024-05-21 | 15.3 | 2024-03-12 | 16.7 |
| 2024-05-20 | 15.5 | 2024-03-11 | 16.4 |
| 2024-05-17 | 15.3 | 2024-03-08 | 15.7 |
| 2024-05-16 | 15.6 | 2024-03-07 | 15.4 |
| 2024-05-15 | 15.2 | 2024-03-06 | 16.6 |
| 2024-05-14 | 15.6 | 2024-03-05 | 16.6 |
| 2024-05-13 | 15.6 | 2024-03-04 | 17.3 |
| 2024-05-10 | 15.8 | 2024-03-01 | 16.3 |
| 2024-05-09 | 16.0 | 2024-02-29 | 16.2 |
| 2024-05-08 | 15.9 | 2024-02-28 | 15.9 |
| 2024-05-07 | 16.1 | 2024-02-27 | 16.0 |
| 2024-05-06 | 16.0 | 2024-02-26 | 16.0 |
| 2024-04-30 | 15.6 | 2024-02-23 | 15.4 |
| 2024-04-29 | 15.9 | 2024-02-22 | 15.5 |
| 2024-04-26 | 15.3 | 2024-02-21 | 15.4 |
| 2024-04-25 | 14.5 | 2024-02-20 | 15.2 |
| 2024-04-24 | 14.6 | 2024-02-19 | 14.8 |
| 2024-04-23 | 14.6 | 2024-02-08 | 14.6 |
| 2024-04-22 | 14.5 | 2024-02-07 | 14.7 |
| 2024-04-19 | 14.4 | 2024-02-06 | 14.3 |
| 2024-04-18 | 14.8 | 2024-02-05 | 13.4 |
| 2024-04-17 | 14.8 | 2024-02-02 | 13.7 |
| 2024-04-16 | 14.3 | 2024-02-01 | 14.5 |
| 2024-04-15 | 14.6 | 2024-01-31 | 13.7 |
| 2024-04-12 | 14.6 | 2024-01-30 | 14.2 |
| 2024-04-11 | 15.0 | 2024-01-29 | 14.6 |
| 2024-04-10 | 15.3 | 2024-01-26 | 14.6 |
| 2024-04-09 | 15.7 | 2024-01-25 | 15.7 |
| 2024-04-08 | 15.3 | 2024-01-24 | 15.4 |
| 2024-04-03 | 16.1 | 2024-01-23 | 15.6 |
| 2024-04-02 | 16.1 | 2024-01-22 | 15.4 |
Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Asymchem Laboratories Tianjin Co Ltd
ISIN : CNE100002BZ6
Share Class Description:
SZSE:002821: Class ACompare
Compare
Traded in other countries / regions
002821.China06821.Hong Kong7K90.Germany IPO Date
2016-11-18Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers